Meristem Family Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.91M | Sell |
56,262
-22,678
| -29% | -$1.18M | 0.31% | 39 |
|
|
2021
Q4 | $4.66M | Buy |
78,940
+464
| +0.6% | +$23K | 0.4% | 37 |
|
|
2021
Q3 | $3.38M | Buy |
78,476
+27,585
| +54% | +$1.22M | 0.33% | 43 |
|
|
2021
Q2 | $1.99M | Buy |
50,891
+2,795
| +6% | +$109K | 0.31% | 41 |
|
|
2021
Q1 | $1.74M | Sell |
48,096
-18,070
| -27% | -$642K | 0.35% | 36 |
|
|
2020
Q4 | $2.44M | Buy |
66,166
+15,385
| +30% | +$564K | 0.52% | 27 |
|
|
2020
Q3 | $1.77M | Buy |
50,781
+119
| +0.2% | +$4.17K | 0.45% | 35 |
|
|
2020
Q2 | $1.57M | Sell |
50,662
-1,946
| -4% | -$66.1K | 0.43% | 36 |
|
|
2020
Q1 | $1.63M | Buy |
52,608
+1,554
| +3% | +$53K | 0.5% | 33 |
|
|
2019
Q4 | $1.9M | Buy |
51,054
+2,432
| +5% | +$86.6K | 0.47% | 34 |
|
|
2019
Q3 | $1.66M | Buy |
48,622
+4,868
| +11% | +$177K | 0.45% | 38 |
|
|
2019
Q2 | $1.8M | Buy |
43,754
+7,914
| +22% | +$314K | 0.55% | 32 |
|
|
2019
Q1 | $1.44M | Sell |
35,840
-453
| -1% | -$18.1K | 0.49% | 35 |
|
|
2018
Q4 | $1.5M | Buy |
36,293
+1,804
| +5% | +$74.9K | 0.55% | 31 |
|
|
2018
Q3 | $1.44M | Sell |
34,489
-1,113
| -3% | -$42.8K | 0.49% | 32 |
|
|
2018
Q2 | $1.23M | Sell |
35,602
-25,992
| -42% | -$888K | 0.43% | 32 |
|
|
2018
Q1 | $2.07M | Hold |
61,594
| – | – | 0.74% | 23 |
|
|
2017
Q4 | $2.12M | Sell |
61,594
-184
| -0.3% | -$6.27K | 0.77% | 22 |
|
|
2017
Q3 | $2.09M | Hold |
61,778
| – | – | 0.84% | 22 |
|
|
2017
Q2 | $1.97M | Hold |
61,778
| – | – | 0.81% | 24 |
|
|
2017
Q1 | $2M | Hold |
61,778
| – | – | 0.79% | 23 |
|
|
2016
Q4 | $1.9M | Sell |
61,778
-889
| -1% | -$27.1K | 0.78% | 25 |
|
|
2016
Q3 | $2.01M | Buy |
62,667
+1,645
| +3% | +$55K | 0.85% | 21 |
|
|
2016
Q2 | $2.04M | Sell |
61,022
-1,483
| -2% | -$47.3K | 0.9% | 19 |
|
|
2016
Q1 | $1.76M | Buy |
62,505
+79
| +0.1% | +$2.26K | 0.78% | 23 |
|
|
2015
Q4 | $1.91M | Hold |
62,426
| – | – | 0.75% | 25 |
|
|
2015
Q3 | $1.86M | Buy |
62,426
+2,044
| +3% | +$65.5K | 0.98% | 22 |
|
|
2015
Q2 | $1.92M | Hold |
60,382
| – | – | 0.84% | 23 |
|
|
2015
Q1 | $1.99M | Buy |
60,382
+211
| +0.4% | +$6.71K | 0.83% | 24 |
|
|
2014
Q4 | $1.78M | Sell |
60,171
-379
| -0.6% | -$10.9K | 0.65% | 29 |
|
|
2014
Q3 | $1.7M | Sell |
60,550
-3,781
| -6% | -$106K | 0.73% | 27 |
|
|
2014
Q2 | $1.81M | Hold |
64,331
| – | – | 0.76% | 26 |
|
|
2014
Q1 | $1.96M | Sell |
64,331
-7,343
| -10% | -$219K | 0.86% | 24 |
|
|
2013
Q4 | $2.08M | Sell |
71,674
-6,052
| -8% | -$176K | 0.86% | 24 |
|
|
2013
Q3 | $2.12M | Sell |
77,726
-3,586
| -4% | -$97.6K | 0.98% | 21 |
|
|
2013
Q2 | $2.16M | Buy |
+81,312
| New | +$2.25M | 1% | 19 |
|
Other funds holding PFE
Meristem Family Wealth's PFE Position: Q1 2022 in Review
Meristem Family Wealth reduced its Pfizer (PFE) stake by 29% in Q1 2022, selling an estimated $1.18M and leaving 56,262 shares worth $2.91M. The position accounts for 0.31% of the portfolio, ranked #39.
Meristem Family Wealth first reported a position in PFE in Q2 2013 and has held it in 36 quarters since. The position peaked at $4.66M in Q4 2021. 3,196 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- Meristem Family Wealth held 56,262 shares of Pfizer worth $2.91M as of Q1 2022.
- Meristem Family Wealth sold 22,678 Pfizer shares in Q1 2022, an estimated $1.18M.
- Pfizer made up 0.31% of Meristem Family Wealth's portfolio in Q1 2022, its #39 holding.
- Meristem Family Wealth first reported a position in Pfizer in Q2 2013 and has held it in 36 quarters since.
- Meristem Family Wealth's Pfizer position peaked at $4.66M in Q4 2021.
- 3,196 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.